Earnings summaries and quarterly performance for Pebblebrook Hotel Trust.
Executive leadership at Pebblebrook Hotel Trust.
Board of directors at Pebblebrook Hotel Trust.
Research analysts who have asked questions during Pebblebrook Hotel Trust earnings calls.
Duane Pfennigwerth
Evercore ISI
4 questions for PEB
Gregory Miller
Truist Securities
4 questions for PEB
Aryeh Klein
BMO Capital Markets
3 questions for PEB
Chris Darling
Green Street
3 questions for PEB
Jay Kornreich
Wedbush Securities
3 questions for PEB
Smedes Rose
Citigroup
3 questions for PEB
Dori Kesten
Wells Fargo & Company
2 questions for PEB
Michael Bellisario
Robert W. Baird & Co.
2 questions for PEB
Ari Klein
BMO Capital Markets
1 question for PEB
Cooper Clark
Wells Fargo
1 question for PEB
Daniel Hogan
Baird
1 question for PEB
Floris Gerbrand van Dijkum
Compass Point Research & Trading, LLC
1 question for PEB
Floris van Dijkum
Compass Point Research & Trading
1 question for PEB
James Feldman
Wells Fargo
1 question for PEB
Kenneth Billingsley
Compass Point Research & Trading LLC
1 question for PEB
Shaun Kelley
Bank of America Merrill Lynch
1 question for PEB
Recent press releases and 8-K filings for PEB.
- Pebblebrook Hotel Trust completed the sale of The Westin Michigan Avenue Chicago for $72.0 million on December 3, 2025.
- For the trailing twelve months ended September 30, 2025, the sold hotel generated $4.6 million in EBITDA and $2.5 million in Net Operating Income (NOI), which equates to a 15.6x EBITDA multiple and a 3.5% NOI capitalization rate.
- Following this sale and the previously announced sale of Montrose at Beverly Hills, Pebblebrook expects to have reduced its outstanding debt by $100 million and preferred securities by approximately $5 million, with an estimated net debt to trailing 12-month corporate EBITDA of approximately 5.9x.
- The company has updated its 2025 outlook, with full-year Adjusted FFO per diluted share expected to range from $1.50 to $1.57, and Q4 2025 Adjusted FFO per diluted share from $0.18 to $0.26. Pebblebrook anticipates no meaningful impact to Adjusted FFO, as lower interest expense from debt reduction is expected to offset the loss of hotel-level EBITDA.
- Pebblebrook Hotel Trust completed the sale of the 752-room Westin Michigan Avenue Chicago for $72 million to local investor Ketu Amin.
- The proceeds from this sale are primarily earmarked for reducing debt and repurchasing common shares.
- This transaction, combined with a previous property sale, has enabled Pebblebrook to reduce its outstanding debt by approximately $100 million and preferred securities by about $5 million, bringing its net debt to trailing 12-month corporate EBITDA ratio to around 5.9x.
- The sale price reflects a 15.6x EBITDA multiple and a 3.5% net operating income capitalization rate, based on the hotel's trailing twelve-month EBITDA of $4.6 million and NOI of $2.5 million.
- Pebblebrook's fourth-quarter and full-year 2025 earnings outlook remains largely unchanged, as the loss of hotel-level EBITDA is expected to be fully offset by reduced interest expenses.
- Pebblebrook Hotel Trust completed the sale of the 133-room Montrose at Beverly Hills for $44.25 million on November 19, 2025.
- Based on the hotel's trailing twelve-month financial performance ended September 30, 2025, the sale price equates to an EBITDA multiple of 16.1x and a net operating income capitalization rate of 5.2%.
- The Company expects to use the sale proceeds for general corporate purposes, including reducing outstanding debt, repurchasing shares, and supporting other capital allocation priorities.
- This transaction is not expected to affect Pebblebrook's current fourth-quarter or full-year 2025 Outlook.
- Pebblebrook also has one other hotel under contract for a sales price of $72.0 million, which is expected to close during the fourth quarter of 2025.
- Pebblebrook Hotel Trust completed the sale of the 133-room Montrose at Beverly Hills for $44.25 million.
- The proceeds from this sale are intended for reducing debt and repurchasing shares.
- The sale price reflects an EBITDA multiple of 16.1x and a net operating income capitalization rate of 5.2%, based on the hotel's trailing twelve-month financials through September 2025.
- This transaction is not expected to impact the company's fourth-quarter or full-year 2025 outlook.
- Additionally, Pebblebrook has another hotel under contract for sale at $72 million, anticipated to close in the fourth quarter.
- Q3 2025 performance was mixed: The resort portfolio saw total RevPAR increase by 0.7%, with Newport Harbor Island Resort's RevPAR jumping 29%. In contrast, urban markets faced challenges, with Washington, D.C. and Los Angeles RevPAR declining 16.4% and 10.4% respectively, accounting for $7 million of the $7.9 million year-over-year decline in same property hotel EBITDA.
- Expense management remained strong: Same property hotel expenses before fixed costs increased by only 0.4% year-over-year in Q3 2025, demonstrating effective cost control.
- Q4 2025 guidance reflects caution: The company projects Q4 same property RevPAR to range between -1.25% and 2%, and total RevPAR between -1.25% and 2.7%, citing macroeconomic uncertainty and the government shutdown as headwinds.
- Optimistic outlook for 2026: Pebblebrook anticipates a positive trajectory for 2026, driven by favorable fundamentals, low new supply, a more advantageous holiday calendar, and significant events. As of October 1, 2026, group room nights were up 4.1% and total revenue pace was up 6.1% or $9 million year-over-year.
- Pebblebrook Hotel Trust reported a net loss of ($32.4) million and Adjusted FFO per diluted share of $0.51 for the third quarter of 2025.
- The company completed a $400 million private offering of 1.625% Convertible Notes due 2030 to retire an equal amount of 1.75% Convertible Notes due 2026, which enhanced liquidity and extended maturities.
- As of September 30, 2025, PEB held $232 million in cash and restricted cash, and its debt carried a 4.1% weighted-average interest rate.
- The Board of Trustees approved a new $150 million common share repurchase program on October 21, 2025, and the company repurchased approximately 4.3 million common shares at $11.56/share during Q3 2025.
- For the full year 2025, the company anticipates an Adjusted FFO per diluted share between $1.50 and $1.57.
- Pebblebrook Hotel Trust reported a net loss of ($32.4) million and Adjusted FFO per diluted share of $0.51 for the third quarter of 2025.
- Same-Property Total RevPAR decreased 1.5% in Q3 2025 compared to Q3 2024, with occupancy increasing by nearly 190 basis points and ADR declining 5.4%. San Francisco achieved 8.3% RevPAR growth, and Chicago increased 2.3%.
- The company completed a $400 million private offering of 1.625% Convertible Notes due 2030 to retire an equal amount of 1.75% Convertible Notes due 2026, and repurchased approximately 4.3 million common shares at $11.56/share. A new $150 million common share repurchase program was approved on October 21, 2025.
- The 2025 outlook was updated, projecting a net loss of ($67.5) to ($58.5) million and Adjusted FFO per diluted share of $1.50 to $1.57, with modest reductions to some midpoints primarily due to the federal government shutdown.
- Pebblebrook Hotel Trust priced and closed a private offering of $400,000,000 aggregate principal amount of its 1.625% Convertible Senior Notes due 2030 on September 18, 2025, which included the full exercise of the initial purchasers' over-allotment option.
- The net proceeds from the offering, approximately $389.7 million, along with $4.1 million of cash on hand, will be used to repurchase approximately $400.0 million aggregate principal amount of its outstanding 1.75% Convertible Senior Notes due 2026.
- The new Notes mature on January 15, 2030, and have an initial conversion rate equivalent to $15.89 per common share, representing a 37.5% conversion premium based on the $11.56 closing price on September 16, 2025.
- Concurrently with the pricing of the Notes, the Company entered into privately negotiated capped call transactions with an initial cap price of $20.23 and repurchased approximately 4.3 million Common Shares at $11.56 per share.
Quarterly earnings call transcripts for Pebblebrook Hotel Trust.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more